Caplin Point Laboratories Limited (BOM:524742)
India · Delayed Price · Currency is INR 2,566.10
-59.05 (-2.25%)
At close: Jul 7, 2026
Caplin Point Laboratories Market Cap
Caplin Point Laboratories has a market cap or net worth of 195.05 billion as of July 7, 2026. Its market cap has increased by 22.46% in one year.
Market Cap
195.05B
Enterprise Value
186.22B
Revenue
21.87B
Ranking
n/a
PE Ratio
30.51
Stock Price
2,566.10
Market Cap Chart
Since February 26, 2002, Caplin Point Laboratories's market cap has increased from 5.60M to 195.05B, an increase of 3,483,622.33%. That is a compound annual growth rate of 53.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 195.05B | 39.37% |
| Dec 31, 2025 | 139.95B | -26.39% |
| Dec 31, 2024 | 190.12B | 84.60% |
| Dec 29, 2023 | 102.99B | 90.47% |
| Dec 30, 2022 | 54.07B | -16.82% |
| Dec 31, 2021 | 65.01B | 69.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 407.07B |
| J. B. Chemicals & Pharmaceuticals | 383.85B |
| Rubicon Research | 224.42B |
| Granules India | 211.72B |
| AstraZeneca Pharma India | 205.56B |
| Jubilant Pharmova | 156.16B |
| Viyash Scientific | 126.31B |
| CORONA Remedies | 121.64B |